What preservative‑free artificial‑tear ophthalmic drops are available in the Philippines for treating dry‑eye disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Preservative-Free Artificial Tear Drops Available in the Philippines

For dry eye disease in the Philippines, use preservative-free sodium hyaluronate 0.1-1% drops or carmellose-based preservative-free artificial tears as first-line therapy, applied 2-4 times daily initially and increased up to hourly based on symptom severity. 1

Primary Product Recommendations

The following preservative-free formulations are recommended for dry eye management:

  • Sodium hyaluronate 0.1-1% preservative-free drops are the preferred first-line option, as they stabilize the tear film, increase corneal wettability, and reduce friction during blinking 1, 2

  • Carmellose sodium (carboxymethylcellulose 0.5-1%) preservative-free drops represent an equally effective alternative with equivalent efficacy to hyaluronate formulations 1, 3

  • Propylene glycol-hydroxypropyl guar (PG-HPG) nanoemulsion drops (such as Systane Complete) provide lipid layer supplementation for evaporative dry eye, forming a cross-linked gel matrix that prolongs retention 4

  • Hydroxypropyl guar-hyaluronic acid (HPG-HA) dual-polymer drops (such as Systane Hydration) combine the benefits of both polymers for synergistic action in multifactorial dry eye 2

Dosing Algorithm Based on Severity

For mild dry eye:

  • Start with preservative-free hyaluronate or carmellose drops 2-4 times daily 1, 3
  • Preserved formulations are acceptable only if frequency remains ≤4 times daily 5, 1

For moderate dry eye:

  • Use preservative-free formulations exclusively, increasing frequency up to hourly as needed 1, 3
  • Add lipid-containing drops if meibomian gland dysfunction is present 5, 3

For severe dry eye:

  • Apply preservative-free drops hourly during daytime 1
  • Add preservative-free ointment at bedtime for overnight protection 6, 3

Critical Prescribing Rules

The mandatory threshold for preservative-free formulations is >4 applications daily - this is not optional but required to prevent ocular surface toxicity from preservatives like benzalkonium chloride 5, 6, 1, 3

  • Preserved drops used more than 4 times daily cause progressive corneal epithelial erosion, ulceration, and conjunctival scarring 1, 7

  • Patients must be explicitly warned against purchasing over-the-counter drops independently, as many contain preservatives or vasoconstricting agents that worsen dry eye 5, 3

When to Escalate Beyond Artificial Tears

If symptoms persist after 2-4 weeks of optimized preservative-free artificial tear therapy:

  • Add topical cyclosporine 0.05% twice daily as second-line anti-inflammatory therapy 1, 3
  • Consider short-term topical corticosteroids (loteprednol 0.5%) for maximum 2-4 weeks during acute exacerbations 5, 1, 3
  • Lifitegrast 5% represents an alternative second-line agent blocking inflammatory pathways 3

Concurrent Management Requirements

  • Treat underlying meibomian gland dysfunction with warm compresses (5-10 minutes) and lid massage daily 3
  • Address anterior blepharitis or Demodex infestation if present, as these exacerbate dry eye 5, 3
  • Review and modify systemic medications contributing to dry eye (anticholinergics, certain antidepressants, antihistamines) 3

Common Pitfalls to Avoid

  • Never use preserved artificial tears more than 4 times daily - this threshold is absolute and non-negotiable 5, 6, 1, 3

  • Do not neglect environmental modifications: increase conscious blinking to >10 times/minute during screen use, avoid air-conditioned environments when possible, and use humidification 5, 3

  • Failing to address concurrent blepharitis or meibomian gland dysfunction will result in treatment failure regardless of artificial tear selection 3

References

Guideline

Preservative-Free Artificial Tears for Dry Eye Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Dry Eye Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ocular Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The use of preservatives in dry eye drops.

Clinical ophthalmology (Auckland, N.Z.), 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.